ATE287404T1 - Diazabicyclo (2.2.1) heptanderivate - Google Patents
Diazabicyclo (2.2.1) heptanderivateInfo
- Publication number
- ATE287404T1 ATE287404T1 AT02700189T AT02700189T ATE287404T1 AT E287404 T1 ATE287404 T1 AT E287404T1 AT 02700189 T AT02700189 T AT 02700189T AT 02700189 T AT02700189 T AT 02700189T AT E287404 T1 ATE287404 T1 AT E287404T1
- Authority
- AT
- Austria
- Prior art keywords
- diseases
- disorders
- diazabicyclo
- nervous system
- heptane derivatives
- Prior art date
Links
- AVGHIQUXSVAJBC-UHFFFAOYSA-N 1,2-diazabicyclo[2.2.1]heptane Chemical class C1C2CCN1NC2 AVGHIQUXSVAJBC-UHFFFAOYSA-N 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 8
- 201000010099 disease Diseases 0.000 abstract 4
- 208000035475 disorder Diseases 0.000 abstract 4
- 210000003169 central nervous system Anatomy 0.000 abstract 2
- 210000001428 peripheral nervous system Anatomy 0.000 abstract 2
- UKHJNJFJCGBKSF-UHFFFAOYSA-N 2,5-diazabicyclo[2.2.1]heptane Chemical class C1NC2CNC1C2 UKHJNJFJCGBKSF-UHFFFAOYSA-N 0.000 abstract 1
- 208000017701 Endocrine disease Diseases 0.000 abstract 1
- 206010061218 Inflammation Diseases 0.000 abstract 1
- 208000002193 Pain Diseases 0.000 abstract 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 abstract 1
- 230000001713 cholinergic effect Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 208000030172 endocrine system disease Diseases 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 230000004770 neurodegeneration Effects 0.000 abstract 1
- 230000000144 pharmacologic effect Effects 0.000 abstract 1
- 230000003389 potentiating effect Effects 0.000 abstract 1
- 230000016160 smooth muscle contraction Effects 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4995—Pyrazines or piperazines forming part of bridged ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Diabetes (AREA)
- Hospice & Palliative Care (AREA)
- Child & Adolescent Psychology (AREA)
- Hematology (AREA)
- Anesthesiology (AREA)
- Psychology (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA200100344 | 2001-03-02 | ||
| PCT/DK2002/000133 WO2002070522A1 (en) | 2001-03-02 | 2002-02-28 | Novel 2,5-diazabicyclo[2.2.1]heptane derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE287404T1 true ATE287404T1 (de) | 2005-02-15 |
Family
ID=8160337
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02700189T ATE287404T1 (de) | 2001-03-02 | 2002-02-28 | Diazabicyclo (2.2.1) heptanderivate |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US7329754B2 (enExample) |
| EP (1) | EP1368348B1 (enExample) |
| JP (1) | JP4294958B2 (enExample) |
| CN (1) | CN1331864C (enExample) |
| AT (1) | ATE287404T1 (enExample) |
| AU (1) | AU2002233181B2 (enExample) |
| CA (1) | CA2438815A1 (enExample) |
| DE (1) | DE60202667T2 (enExample) |
| DK (1) | DK1368348T3 (enExample) |
| MX (1) | MXPA03007895A (enExample) |
| NZ (1) | NZ527006A (enExample) |
| WO (1) | WO2002070522A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2002352878B2 (en) * | 2001-11-27 | 2007-11-22 | Merck Sharp & Dohme Corp. | 2-Aminoquinoline compounds |
| KR20100101171A (ko) * | 2008-02-15 | 2010-09-16 | 에프. 호프만-라 로슈 아게 | 3-알킬-피페라진 유도체 및 이의 용도 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IN166416B (enExample) * | 1985-09-18 | 1990-05-05 | Pfizer | |
| US5196548A (en) * | 1989-05-11 | 1993-03-23 | Pfizer Inc. | Preparation of diazabicyclic Intermediates |
| JPH06228138A (ja) * | 1993-02-03 | 1994-08-16 | Fujisawa Pharmaceut Co Ltd | ピリドシンノリン化合物またはその塩及びこれを含有する抗菌剤 |
| US5478939A (en) * | 1994-07-20 | 1995-12-26 | American Cyanamid Company | (R,R) and (S,S) 2,5-diazabicyclo [2,2,1]heptane derivatives |
| US5561127A (en) * | 1994-12-19 | 1996-10-01 | Allelix Biopharmaceuticals, Inc. | Muscarinic receptor ligands |
| FR2786769B1 (fr) | 1998-12-04 | 2002-10-25 | Synthelabo | Derives de 2,5-diazabicyclo[2.2.1]heptane, leur preparation et leur application en therapeutique |
| EP1147112B1 (en) * | 1999-01-29 | 2003-10-29 | Abbott Laboratories | Diazabicyclic derivatives as nicotinic acetylcholine receptor ligands |
| EP1289996B1 (en) * | 2000-05-25 | 2005-04-06 | Targacept, Inc. | Heteroaryldiazabicycloalkanes as nicotinic cholinergic receptor ligands |
| CA2354606C (en) | 2000-08-03 | 2005-12-06 | Pfizer Products Inc. | Azabicycloalkane derivatives and therapeutic uses thereof |
-
2002
- 2002-02-28 NZ NZ527006A patent/NZ527006A/en unknown
- 2002-02-28 US US10/250,765 patent/US7329754B2/en not_active Expired - Fee Related
- 2002-02-28 AT AT02700189T patent/ATE287404T1/de not_active IP Right Cessation
- 2002-02-28 CA CA002438815A patent/CA2438815A1/en not_active Abandoned
- 2002-02-28 JP JP2002569842A patent/JP4294958B2/ja not_active Expired - Fee Related
- 2002-02-28 CN CNB028050770A patent/CN1331864C/zh not_active Expired - Fee Related
- 2002-02-28 DE DE60202667T patent/DE60202667T2/de not_active Expired - Lifetime
- 2002-02-28 AU AU2002233181A patent/AU2002233181B2/en not_active Ceased
- 2002-02-28 EP EP02700189A patent/EP1368348B1/en not_active Expired - Lifetime
- 2002-02-28 WO PCT/DK2002/000133 patent/WO2002070522A1/en not_active Ceased
- 2002-02-28 MX MXPA03007895A patent/MXPA03007895A/es active IP Right Grant
- 2002-02-28 DK DK02700189T patent/DK1368348T3/da active
Also Published As
| Publication number | Publication date |
|---|---|
| NZ527006A (en) | 2005-02-25 |
| DE60202667D1 (de) | 2005-02-24 |
| CA2438815A1 (en) | 2002-09-12 |
| DE60202667T2 (de) | 2005-06-16 |
| JP4294958B2 (ja) | 2009-07-15 |
| AU2002233181B2 (en) | 2007-06-07 |
| CN1535273A (zh) | 2004-10-06 |
| DK1368348T3 (da) | 2005-05-23 |
| CN1331864C (zh) | 2007-08-15 |
| US20040181069A1 (en) | 2004-09-16 |
| EP1368348A1 (en) | 2003-12-10 |
| WO2002070522A1 (en) | 2002-09-12 |
| MXPA03007895A (es) | 2003-12-04 |
| JP2004529901A (ja) | 2004-09-30 |
| US7329754B2 (en) | 2008-02-12 |
| EP1368348B1 (en) | 2005-01-19 |
| HK1068878A1 (en) | 2005-05-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL166254A0 (en) | Novel quinuclidine derivatives and their use | |
| PL375025A1 (en) | Novel 1,4-diazabicycloalkane derivatives, their preparation and use | |
| AU2002220517A1 (en) | 3-substituted quinuclidines and their use as nicotinic agonists | |
| AU6583101A (en) | Aryl and heteroaryl diazabicycloalkanes, their preparation and use | |
| ATE348831T1 (de) | Diazabicyclische biarylderivate | |
| AU2003280309A1 (en) | 1,4-diazabicyclo (3,2,2)nonane derivatives, preparation and therapeutical use thereof | |
| ATE289310T1 (de) | Heteroaryl-diazabicycloalkanderivaten als cns- modulatoren | |
| MXPA04000012A (es) | Compuestos novedosos, su preparacion y uso. | |
| MXPA05006861A (es) | Derivados arildiazabiciclicos novedosos. | |
| ATE437880T1 (de) | Dimere azacyclische verbindungen und deren verwendung | |
| DE60307102D1 (de) | 3-substituierte chinuklidine und deren verwendung | |
| ATE492279T1 (de) | Bupropinmetaboliten zur behandlung von dementia und anderen zerebrovasckulären erkrankungen | |
| MXPA04010965A (es) | Derivados de etinilo azaciclico novedoso. | |
| DE60202667D1 (de) | Diazabicyclo [2.2.1] heptanderivate | |
| DE602004031124D1 (de) | Neue chinuklidinderivative und deren pharmazeutische verwendung | |
| MX2007004245A (es) | Nuevos derivados de arilo azabiciclicos y su uso medico. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1368348 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |